- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05420090
The Effects of Milk and Banana as a Night Meal to Primary Insomnia on Sleep Quality, BDNF and Appetite Mechanism (diet)
July 18, 2023 updated by: Saglik Bilimleri Universitesi
The Effects of Milk and Banana Given as a Night Meal to Individuals Diagnosed With Sleep Disorders on Sleep Quality, BDNF and Appetite Mechanism
The aim of this study to determine the impact of banana and milk on sleep and appetite
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sleep is one of the main components of the continuity of circadian rhythm.
It restores energy and enhancement, memory.
Sleep disturbances and short sleep duration are important risk factors for many diseases.
Nutrition is one of the main determinants of health status in many diseases related to inflammation.
Especially the night meal, known as the foods consumed before bedtime, has a strong effect on sleep.
Although there are methodological differences, most studies show that unhealthy eating habits are associated with short sleep duration.
It is thought that consuming foods with high tryptophan and melatonin content can reduce sleep problems.
This study will give a chance to observe the effects of nutrients on sleep and appetite mechanisms.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Konya, Turkey
- Selcuk University Medical Faculty
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Applying to the Sleep Polyclinic,
- 18-45 years old,
- Body Mass Index (BMI) between 18.5-25 kg/m2,
- Male and female patients diagnosed with primary sleep disorder for the first time
Exclusion Criteria:
- Individuals with any psychiatric illness,
- Those who use cigarettes, alcohol, drugs or sedative drugs,
- Individuals with any chronic disease (diabetes, etc.),
- Pregnant and/or lactating
- Individuals with lactose intolerance,
- athletes,
- Individuals who are allergic to bananas
- Individuals with lactose intolerance or milk intolerance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: eating banana for 6 weeks before bedtime
Participants will consume 1 portion of banana (gross 80-85 g) given to them for 6 weeks, approximately 45 minutes-1 hour before bedtime.
|
Venous blood samples will be taken from the participants in 3 groups before starting the study.
Pittsburgh Sleep Quality Index will be applied.Food consumption frequency and food-based follow-up will be carried out.Participants will consume 1 portion of banana (gross 80-85 g) given to them for 6 weeks, approximately 45 minutes-1 hour before bedtime.
The frequency of food consumption will be taken from the participants each week.
|
Experimental: drinking milk for 6 weeks before bedtime
Participants will consume 200 ml of whole milk given to them for 6 weeks, approximately 45 minutes-1 hour before bedtime.
|
Venous blood samples will be taken from the participants in 3 groups before starting the study.
Pittsburgh Sleep Quality Index will be applied.
Food consumption frequency and food-based follow-up will be carried out.
Participants will consume 200 ml of whole milk given to them for 6 weeks, approximately 45 minutes-1 hour before bedtime.
The frequency of food consumption will be taken from the participants each week.
|
Experimental: Control
Not making any changes in diet
|
Venous blood samples will be taken from the participants in 3 groups before starting the study.
Pittsburgh Sleep Quality Index will be applied.
The frequency of food consumption will be taken from the participants each week.Participants are expected not to make any changes in their diet.
As in other groups, the frequency of food consumption will be taken from the participants every week in this group.
In order to observe the possible changes in the experimental arms, the individuals in the control arm will be asked not to consume bananas and whole milk after 16:00 and they will be informed about this.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changing Score on the Pittsburgh Sleep Quality Index (PSQI) from baseline
Time Frame: at baseline, 6. week
|
Change from baseline PSQI at 6 weeks
|
at baseline, 6. week
|
Level of Brain Derived Neurotrophic Factor (pg/ml)
Time Frame: at baseline, 6. week
|
Fasting (less than 12 hrs) venous blood samples were collected from all the participants and centrifugation of the specimen was done (ng/ml)
|
at baseline, 6. week
|
Level of Leptin (mg/dl)
Time Frame: at baseline, 6. week
|
Fasting (less than 12 hrs) venous blood samples were collected from all the participants and centrifugation of the specimen was done (ng/ml)
|
at baseline, 6. week
|
Level of Ghrelin (mg/dl)
Time Frame: at baseline and 6. week
|
Fasting (less than 12 hrs) venous blood samples were collected from all the participants and centrifugation of the specimen was done (ng/ml))
|
at baseline and 6. week
|
Evaluate stages of sleep and the oxygen level in blood
Time Frame: at baseline and 6. week
|
Polymsomnography is used for the diagnosis and treatment plan of sleep disorder and sleep architecture
|
at baseline and 6. week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nutrient intake (g/day)
Time Frame: 6 consecutive weeks, 6 weeks
|
assessed by a food frequency record as g/day
|
6 consecutive weeks, 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Muteber Gizem KESER, PhD,Lecturer, KTO Karatay University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Actual)
May 30, 2023
Study Completion (Actual)
June 30, 2023
Study Registration Dates
First Submitted
June 1, 2022
First Submitted That Met QC Criteria
June 14, 2022
First Posted (Actual)
June 15, 2022
Study Record Updates
Last Update Posted (Actual)
July 20, 2023
Last Update Submitted That Met QC Criteria
July 18, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0001 (Cancer Research Institute)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Insomnia
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
IWK Health CentreUnknownPrimary Insomnia | Nonorganic InsomniaCanada
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States
-
University of RochesterSanofi-SynthelaboCompletedInsomnia | Primary Insomnia | Psychophysiologic InsomniaUnited States
-
US Department of Veterans AffairsCompletedInsomnia | Primary Insomnia | Secondary InsomniaUnited States
-
University of UtahEvans Army Community HospitalCompletedPrimary Insomnia | Secondary InsomniaUnited States
-
University of WashingtonUnknownChronic Insomnia | Insomnia, Primary
-
Jack Edinger, PhDMerck Sharp & Dohme LLCCompletedInsomnia | Primary Insomnia | Chronic InsomniaUnited States
-
University of PittsburghCompletedInsomnia Chronic | Insomnia, PrimaryUnited States
-
Eli Lilly and CompanyCompletedAn Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia (SLUMBER)Primary Insomnia | Secondary InsomniaUnited States
Clinical Trials on Banana arm
-
Appalachian State UniversityDole Food CompanyCompleted
-
Chulalongkorn UniversityCompletedPreterm Birth | Postpartum WomenThailand
-
TCI Co., Ltd.Active, not recruiting
-
Appalachian State UniversityDole Food CompanyCompletedInflammatory Response | Metabolic Disturbance | Immune SuppressionUnited States
-
TCI Co., Ltd.RecruitingBenign Prostatic Hyperplasia (BPH)Taiwan
-
TCI Co., Ltd.Completed
-
Federal University of São PauloUnknownDiabetes Mellitus | Pre-diabetesBrazil
-
University of ManitobaPulse CanadaCompleted
-
Augusta UniversityNRS Medical College, Kolkata, West Bengal, India; School of Tropical Medicine...Terminated
-
University of ReadingCompletedCardiovascular DiseasesUnited Kingdom